South Korean chip maker SK Hynix and US private-equity firm Bain Capital plan to bid between $9 billion and $13.5 billion for more than half of Toshiba Corp.’s memory-chip business, according to a person familiar with the matter.
“Regarding the acquisition of management stake of Toshiba’s memory unit, we decided to join the final bid in partnership with a consortium,” the Korean chipmaker said in its regulatory filing Friday afternoon.
SK hynix reportedly joined the consortium led by Bain Capital, which has set up a special-purpose company to acquire a 51 percent stake of Toshiba’s memory unit.
Investment in part of the stake — rather than complete acquisition — could also help the consortium circumvent antitrust regulations.
Japanese newspaper Nihon Geizai Shimbun estimated that the total investment volume of the special-purpose company would be a little more than 1 trillion yen ($8 billion) but it is yet unknown how much SK hynix will set aside.
Bain Capital is expected to sound out the government-backed fund Innovation Network Corp. of Japan about joining as a small shareholder. If the local fund joins, the move might dispel the Japanese government’s concerns about technology leaks to foreign companies.
Full Content: Asia Nikkei
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Rumble Adds David Boies to Legal Team in $2 Billion Antitrust Battle with Google
May 14, 2025 by
CPI
China Summons Delivery Giants Over Unfair Competition Concerns
May 13, 2025 by
CPI
Judge Orders Sanctions Against Missouri for Noncompliance in Price-Fixing Probe
May 13, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas